Subscribe to receive our weekly news directly into your email inbox
Subscribe to receive our weekly news directly into your email inbox
The World In A Week – Cheque Mate
January 18, 2021
The political situation in the US continued to dominate the news headlines last week with President Trump impeached for the second time during his term. National Guard troops have been deployed to…
The World In A Week – White House Down
January 11, 2021
Not to be outshone by its predecessor, 2021 gave us an unexpected first week of the year. Politically, this was going to be an important week in America. We had the final two seats in the Senate…
The World In A Week – “That’s All Folks!”
January 4, 2021
As Michael Caine famously said in the iconic movie The Italian Job, “You’re only supposed to blow the bloody doors off!” Which seems to sum up 2020 well – it’s not what we wanted, not what we…
The World In A Week – Casting Our Net
December 14, 2020
After several weeks of non-stop gains, driven by vaccination hopes, markets paused for breath. The Food & Drug Administration in the US granted emergency approval for the use of the…
The World In A Week – Fishing For A Solution
December 7, 2020
We have had Brexit looming in the background, with its 11 month countdown, since we officially left the European Union on 31st January 2020. Will we see a deal brokered at the 11th hour? The most…
The World In A Week – Will The Year End In Tiers?
November 30, 2020
A fresh round of vaccine optimism underpinned another strong week for global equities with benchmarks hitting fresh new highs, including the Dow Jones Industrial Average crossing the 30,000 points…
The World In A Week – Vaccine Variety
November 23, 2020
Last week was a broadly positive environment, which continued the buoyant mood of the markets over the course of November to date. Global Equities, as measured by MSCI All Country World Index (ACWI)…
The World In A Week – The Cummings And Goings Of UK Politics
November 16, 2020
Hot off the back of Biden’s election victory, Pfizer and BioNTech announced that phase III trials for a vaccine against COVID-19 were 90% effective and, unlike previous trials, there also appears to…